News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines were released in the past hour.
  • No scheduled economic data or central-bank announcements occurred during the past hour.
  • No significant corporate earnings, M&A filings, or IPOs were reported in the past hour.
  • No new geopolitical incidents or government policy shifts were reported in the past hour.
  • No material regulatory actions or legal rulings affecting markets were announced in the past hour.
  • News flow was light, leaving markets without fresh catalysts in the past hour.

Latest Articles

Wetour Robotics Launches Vantrapower to Expand into Intelligent Power Infrastructure for AI Industrial and Energy Markets in Texas

Wetour Robotics Launches Vantrapower to Expand into Intelligent Power Infrastructure for AI Industrial and Energy Markets in Texas

Wetour Robotics Limited has launched Vantrapower LLC, a new Texas-based subsidiary focused on supplying transformers and power infrastructure solutions for data centers, industrial facilities, energy storage, and other high-load applications. The initiative aims to expand the company's presence in AI infrastructure and automation for computing, ind…

Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer

Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer

Precision Optics Corporation announced a $50,000 initial development order from a U.S. space technology company developing a new satellite constellation. The order supports early engineering work on laser communication subassemblies for Optical Communication Terminals, representing the company's second satellite customer and an important growth dri…

Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing

Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing

Creative Medical Technology Holdings, Inc. announced the filing of a new U.S. provisional patent application aimed at broadening intellectual property protection around its Ultrasome™, a proprietary cell-free regenerative medicine platform. The filing covers multiple aspects of the platform including product composition, biological potency, manufac…

Game Your Game Appoints Mujtaba Elgoodah as Strategic Advisor

Game Your Game Appoints Mujtaba Elgoodah as Strategic Advisor

Game Your Game, an AI-powered sports performance technology company listed on Nasdaq as GYGY, announced the appointment of Mujtaba Elgoodah as Strategic Advisor to support its expansion efforts for its GameGolf platform and Altus Sports Group subsidiary. Elgoodah brings valuable expertise from sports, technology, media, and investment sectors, expe…

NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates

NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates

NeOnc Technologies eliminated a significant dilution risk by redeeming all outstanding Series A Convertible Preferred Stock for $6 million in cash without issuing common shares, following a $15 million registered direct offering. The company is progressing its CNS cancer drug pipeline, reporting positive Phase 2a results for NEO100 in recurrent IDH…

Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors

Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors

Ernexa Therapeutics appointed Dr. Robert J. Spiegel, a seasoned oncology and biopharmaceutical leader, to its Board of Directors. Dr. Spiegel's extensive experience in clinical development, regulatory affairs, and oncology drug approval is expected to support the progression of Ernexa's lead cell therapy candidate, ERNA-101, into clinical evaluatio…

National Fuel Gas Company Announces Timeline to Conclude Evaluation of a Plan to Separate into Two Independent Publicly Traded Companies

National Fuel Gas Company Announces Timeline to Conclude Evaluation of a Plan to Separate into Two Independent Publicly Traded Companies

National Fuel Gas Company announced it is evaluating a plan to separate into two independent publicly traded companies by October 15, 2026. The split would create one company focusing on regulated natural gas utility and pipeline/storage assets, and another on integrated upstream and gathering operations in Appalachia. This separation aims to enhan…

Salesforce Goes Headless: A Quiet Platform Shift That Deserves a Trade

Salesforce Goes Headless: A Quiet Platform Shift That Deserves a Trade

Salesforce's pivot to headless commerce and composable experience layers is a strategic lever that could widen platform adoption and improve monetization per account. The market appears focused on macro growth metrics, not on incremental platform stickiness created by API-first architecture. This trade targets a re-rating as adoption and product mi…

NeoVolta Announces Capacity Reservation Agreement with Infinite Grid Capital Ahead of Pendergrass Facility Grand Opening

NeoVolta Announces Capacity Reservation Agreement with Infinite Grid Capital Ahead of Pendergrass Facility Grand Opening

NeoVolta Inc. announced a binding capacity reservation agreement with Infinite Grid Capital to provide battery energy storage systems for Northern Ontario Edge AI Data Center projects, marking the first commercial commitment under a $200 million utility-scale framework. This milestone coincides with the grand opening of NeoVolta's Pendergrass, Geor…

Duke Robotics Appoints Capital Markets and Public Company Finance Veteran Avi Levin as Chief Financial Officer

Duke Robotics Appoints Capital Markets and Public Company Finance Veteran Avi Levin as Chief Financial Officer

Duke Robotics Corp., a Nasdaq-listed advanced robotics and drone solutions company, announced the appointment of Avi Levin as Chief Financial Officer, effective October 1, 2026. Levin brings extensive experience in Nasdaq companies and capital markets, expected to support Duke's growth strategy as it scales its drone platforms in defense and civili…

Pasqal to Ring Nasdaq Closing Bell on September 17th

Pasqal to Ring Nasdaq Closing Bell on September 17th

Pasqal, a global leader in neutral-atom quantum computing, announced its recent public listing on Nasdaq under ticker symbol PSQL, commemorated by ringing the Nasdaq Closing Bell on September 17, 2026. The company aims to accelerate deployment of its quantum computing platforms for commercial and public-sector applications worldwide, leveraging its…

TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD

TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD

TOMI Environmental Solutions reports strong growth in its SteraMist Integrated System (SIS) product line, with $2.3 million in enclosure purchase orders year-to-date, exceeding the prior four years combined by 44%. The SIS platform’s standardized packages enable faster closing and retrofit of existing equipment, enhancing customer adoption especial…

Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity

Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity

Nuwellis, Inc. reported strong commercial momentum for its Aquadex SmartFlow system with 31 console sales year-to-date in 2026, surpassing full-year sales in most of the prior decade and positioning the company for one of its top sales years. This growth, alongside 26% year-over-year U.S. revenue increase in H1 2026 across pediatric, critical care,…